In a controversial maneuver, the Massachusetts attorney general is threatening to file a lawsuit against Gilead Sciences if the California drug maker doesn’t lower its prices for a pair of costly hepatitis C treatments.
Legal experts are calling this a long shot. Consumer advocates believe this is a brilliant tactic. And in truth, both sides have a point.
Read Full Article »